BWI: Ocimum Biosolutions is India’s 4th Fastest Growing Technology Company

Press release from Business Wire India
Source: Ocimum Biosolutions
Friday, December 18, 2009 12:10 PM IST (06:40 AM GMT)
Editors: General: Consumer interest; Business: Accounting & management consultancy services, Advertising, PR & marketing, Business services, Healthcare, biotechnology & pharmaceutical; Technology; Healthcare
--------------------------------------------------
Ocimum Biosolutions is India's 4th Fastest Growing Technology Company
Ranked 42 on Deloitte Technology Fast 500 Asia Pacific 2009 Program

Hyderabad, Andhra Pradesh, India and Gaithersburg, Maryland, United States, Friday, December 18, 2009 -- (Business Wire India) -- Ocimum Biosolutions, a leading integrated genomics company, today announced that it ranked 42nd on the Deloitte Technology Fast 500 Asia Pacific 2009, a ranking of the 500 fastest growing technology companies in Asia Pacific. Rankings are based on percentage revenue growth over three years. In addition to ranking on Deloitte's Technology Fast 500, Ocimum ranked fourth on the Technology Fast 50 India Program, which is a ranking of the 50 fastest growing technology firms in India.

Earlier this year the INC magazine listed Ocimum as one the fastest growing companies in North America. Ocimum offers a global genomics infrastructure that includes GLP compliant labs, gold standard databases, biorepository and analytics on hosted data management platform. The company is building a state-of-the-art facility at their corporate headquarters in Hyderabad which will mirror the GLP and CLIA facilities available in Gaithersburg.

Anu Acharya, CEO, Ocimum Biosolutions said that "We have always let customers' needs drive our priorities. As the pharma and biotech industry evolves, the need for a global genomics infrastructure is desired. Ocimum has all the elements and we have created an infrastructure where we take on complete accountability to create consistent data for our customers."

She added, "We are indebted to our growing list of global customers, who have trusted us over the years, referred us as partners in their R&D efforts. This has helped us continuously expand our portfolio and offer unique range of integrated solutions."

"Being one of the 500 fastest growing technology companies in Asia Pacific is an impressive accomplishment. We commend Ocimum Biosolutions for making the Deloitte Technology Fast 500 Asia Pacific with a phenomenal 663% growth rate over five years," said Yoshitaka Asaeda, partner in charge of Deloitte's Technology Fast 500 Asia Pacific program.

Technology Fast 500 Asia Pacific Selection and Qualifications

The Technology Fast 500 list is compiled from Deloitte's Technology Fast 50 Asia Pacific programs, nominations submitted directly to the Technology Fast 500, and public company database research. To qualify for the Technology Fast 500, entrants must have had first year operating revenues of at least US$50,000.

Entrants must also be public or private companies headquartered in Asia Pacific and must be a "technology company," defined as a company that owns proprietary technology that contributes to a significant portion of the company's operating revenues; Manufactures a technology related product, or devotes a significant proportion of revenues to the research and development of technology.

About Ocimum Biosolutions

Ocimum Biosolutions is a global integrated genomics services company with operations in Hyderabad, India, Gaithersburg, MD in the US and The Netherlands. Ocimum provides comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.

Our global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating the world's largest commercial gene expression databases - BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. Ocimum has been consistently ranked as India's fastest growing biotechnology company and one of the fastest growing technology companies over the last four years by Deloitte Touche Tohmatsu.

For more information, please visit www.ocimumbio.com.

About Deloitte

Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 140 countries, Deloitte brings world-class capabilities and deep local expertise to help clients succeed wherever they operate. Deloitte's more than 168,000 professionals are committed to becoming the standard of excellence.

Deloitte's professionals are unified by a collaborative culture that fosters integrity, outstanding value to markets and clients, commitment to each other, and strength from cultural diversity. They enjoy an environment of continuous learning, challenging experiences, and enriching career opportunities. Deloitte's professionals are dedicated to strengthening corporate responsibility, building public trust, and making a positive impact in their communities.

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu and its member firms.


CONTACT DETAILS
Ms. Dhanya Menon, Ocimum Biosolutions, +91 (40) 66986700, pr@ocimumbio.com

KEYWORDS
CONSUMER, CONSULTANCY SERVICES, MARKETING, BUSINESS SERVICES, HEALTHCARE, TECHNOLOGY, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com